These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 2269683

  • 21. Insulin-degrading enzyme does not require peroxisomal localization for insulin degradation.
    Chesneau V, Perlman RK, Li W, Keller GA, Rosner MR.
    Endocrinology; 1997 Aug; 138(8):3444-51. PubMed ID: 9231799
    [Abstract] [Full Text] [Related]

  • 22. Investigation into the presence of insulin-degrading enzyme in cultured type II alveolar cells and the effects of enzyme inhibitors on pulmonary bioavailability of insulin in rats.
    Hsu MC, Bai JP.
    J Pharm Pharmacol; 1998 May; 50(5):507-14. PubMed ID: 9643444
    [Abstract] [Full Text] [Related]

  • 23. Isolation of a spontaneously fusing BC3H1 muscle cell line: fusion alters the response to serum stimulation.
    Steenstrup T, Hannon K.
    In Vitro Cell Dev Biol Anim; 2000 Apr; 36(4):241-8. PubMed ID: 10852349
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III.
    Ding L, Becker AB, Suzuki A, Roth RA.
    J Biol Chem; 1992 Feb 05; 267(4):2414-20. PubMed ID: 1733942
    [Abstract] [Full Text] [Related]

  • 25. Partial characterization of an endogenous inhibitor of a calcium-dependent form of insulin protease.
    Ryan MP, Duckworth WC.
    Biochem Biophys Res Commun; 1983 Oct 14; 116(1):195-203. PubMed ID: 6357196
    [Abstract] [Full Text] [Related]

  • 26. Drosophila insulin degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites.
    Duckworth WC, Garcia JV, Liepnieks JJ, Hamel FG, Hermodson MA, Frank BH, Rosner MR.
    Biochemistry; 1989 Mar 21; 28(6):2471-7. PubMed ID: 2659071
    [Abstract] [Full Text] [Related]

  • 27. Correlation between fusion and the developmental regulation of membrane glycoproteins in L6 myoblasts.
    Rosenberg J, Szabo A, Rheuark D, Kayalar C.
    Proc Natl Acad Sci U S A; 1985 Dec 21; 82(24):8409-13. PubMed ID: 3909144
    [Abstract] [Full Text] [Related]

  • 28. Control of differentiation in BC3H1 muscle cells.
    Glaser L, Wice B.
    Environ Health Perspect; 1989 Mar 21; 80():143-8. PubMed ID: 2924753
    [Abstract] [Full Text] [Related]

  • 29. Identification of the metal associated with the insulin degrading enzyme.
    Ebrahim A, Hamel FG, Bennett RG, Duckworth WC.
    Biochem Biophys Res Commun; 1991 Dec 31; 181(3):1398-406. PubMed ID: 1764090
    [Abstract] [Full Text] [Related]

  • 30. ATP inhibits insulin-degrading enzyme activity.
    Camberos MC, Pérez AA, Udrisar DP, Wanderley MI, Cresto JC.
    Exp Biol Med (Maywood); 2001 Apr 31; 226(4):334-41. PubMed ID: 11368426
    [Abstract] [Full Text] [Related]

  • 31. Immunochemical studies on the insulin-degrading enzyme from pig and rat skeletal muscle.
    Yokono K, Imamura Y, Shii K, Mizuno N, Sakai H, Baba S.
    Diabetes; 1980 Oct 31; 29(10):856-9. PubMed ID: 6777221
    [Abstract] [Full Text] [Related]

  • 32. Multiple controls for the synthesis of muscle-specific proteins in BC3H1 cells.
    Munson R, Caldwell KL, Glaser L.
    J Cell Biol; 1982 Feb 31; 92(2):350-6. PubMed ID: 7061588
    [Abstract] [Full Text] [Related]

  • 33. Culture of C2C12 and BC3H1 myogenic cells with iron-supplemented calf serum; rapid media screen.
    Sharp SB, Lee M, Enriquez E, Ghebremedhin A, Momjian P, Kim S, Sunday L, Villalvazo M, Carvajal LS, Avari S.
    In Vitro Cell Dev Biol Anim; 1995 Nov 31; 31(10):749-51. PubMed ID: 8564062
    [No Abstract] [Full Text] [Related]

  • 34. Insulin degradation by human skeletal muscle.
    Neal GW, Kitabchi AE.
    Biochim Biophys Acta; 1982 Nov 24; 719(2):259-66. PubMed ID: 6758860
    [Abstract] [Full Text] [Related]

  • 35. Expression of acetylcholine receptor alpha-subunit mRNA during differentiation of the BC3H1 muscle cell line.
    Olson EN, Glaser L, Merlie JP, Lindstrom J.
    J Biol Chem; 1984 Mar 10; 259(5):3330-6. PubMed ID: 6699020
    [Abstract] [Full Text] [Related]

  • 36. Regulation of surface expression of acetylcholine receptors in response to serum and cell growth in the BC3H1 muscle cell line.
    Olson EN, Glaser L, Merlie JP, Sebanne R, Lindstrom J.
    J Biol Chem; 1983 Nov 25; 258(22):13946-53. PubMed ID: 6643459
    [Abstract] [Full Text] [Related]

  • 37. Possible role of cell surface insulin degrading enzyme in cultured human lymphocytes.
    Yaso S, Yokono K, Hari J, Yonezawa K, Shii K, Baba S.
    Diabetologia; 1987 Jan 25; 30(1):27-32. PubMed ID: 3552818
    [Abstract] [Full Text] [Related]

  • 38. Preparation and characterization of novel substrates of insulin proteinase (EC 3.4.99.45).
    Werlen RC, Offord RE, Rose K.
    Biochem J; 1994 Sep 15; 302 ( Pt 3)(Pt 3):907-11. PubMed ID: 7945219
    [Abstract] [Full Text] [Related]

  • 39. Characterization of an insulin degrading enzyme from cultured human lymphocytes.
    Roth RA, Mesirow ML, Cassell DJ, Yokono K, Baba S.
    Diabetes Res Clin Pract; 1985 Mar 15; 1(1):31-9. PubMed ID: 3915257
    [Abstract] [Full Text] [Related]

  • 40. Effects of p-phenylenediamines and adriamycin on primary culture of rat skeletal muscle cells.
    Harauchi T, Hirata M.
    Toxicol Lett; 1993 Jan 15; 66(1):35-46. PubMed ID: 8427019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.